BioCryst to Report Second Quarter 2026 Financial Results on August 5
Go back to BioCryst to Report Second Quarter 2026 Financial Results on August 5| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 8.70 +0.27 (3.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.43 | 52 Week High | $10.98 | |||
| Open | $8.54 | 52 Week Low | $1.63 | |||
| Day High | $8.73 | P/E | N/A | |||
| Day Low | $8.43 | EPS | $-0.68 | |||
| Volume | 5,219,505 | |||||
